Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 21,650 | 14,999 | 14,549 | 10,591 | 13,082 |
| Cost of Goods | 8,740 | 2,512 | 1,265 | 3,051 | 2,580 |
| Gross Profit | 4,720 | 12,487 | 13,284 | 7,540 | 10,510 |
| Operating Expenses | 20,950 | 17,488 | 17,431 | 14,707 | 10,820 |
| Operating Income | -7,300 | -4,489 | -3,882 | -7,116 | 262 |
| Interest Expense | 60 | 60 | 103 | 64 | 50 |
| Other Income | -830 | 1,431 | 1,131 | -45 | -1,602 |
| Pre-tax Income | -8,190 | -3,118 | -2,854 | -7,225 | -1,390 |
| Net Income Continuous | -8,455 | -3,118 | -2,854 | -7,225 | -1,382 |
| Net Income | $-8,455 | $-3,118 | $-2,854 | $-8,788 | $-1,382 |
| EPS Basic Total Ops | -0.23 | -0.09 | -0.08 | -0.28 | -0.04 |
| EPS Basic Continuous Ops | -0.23 | -0.09 | -0.08 | -0.23 | -0.04 |
| EPS Diluted Total Ops | -0.23 | -0.09 | -0.08 | -0.28 | -0.04 |
| EPS Diluted Continuous Ops | -0.23 | -0.09 | -0.08 | -0.23 | -0.04 |
| EBITDA(a) | $-6,005 | $-3,335 | $-2,837 | $-6,190 | $1,232 |